JG
FLNA

Jefferies Group’s Filana Therapeutics FLNA Stock Holding History

Jefferies Group’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$16.9M Sell
403,100
-266,100
-40% -$7.19M 0.14% 114
2022
Q2 		$18.8M Buy
669,200
+234,300
+54% +$5.92M 0.16% 97
2022
Q1 		$16.2M Buy
+434,900
New +$18.4M 0.1% 157
2021
Q4 		– Sell
-100,000
Closed -$6.21M – 1950
2021
Q3 		$6.21M Buy
100,000
+85,000
+567% +$7.09M 0.05% 383
2021
Q2 		$1.28M Buy
+15,000
New +$804K 0.01% 900

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jefferies Group's FLNA Position: Q3 2022 in Review

Jefferies Group reduced its Filana Therapeutics (FLNA) stake by 41% in Q3 2022, selling an estimated $657K and leaving 34,753 shares worth $1.45M. The position accounts for 0.01% of the portfolio, ranked #703.

Jefferies Group first reported a position in FLNA in Q4 2019 and has held it in 9 quarters since. The position peaked at $1.66M in Q2 2022. 175 funds tracked by Wall St. Rank hold FLNA as of Q3 2022.

  • Jefferies Group held 34,753 shares of Filana Therapeutics worth $1.45M as of Q3 2022.
  • Jefferies Group sold 24,310 Filana Therapeutics shares in Q3 2022, an estimated $657K.
  • Filana Therapeutics made up 0.01% of Jefferies Group's portfolio in Q3 2022, its #703 holding.
  • Jefferies Group first reported a position in Filana Therapeutics in Q4 2019 and has held it in 9 quarters since.
  • Jefferies Group's Filana Therapeutics position peaked at $1.66M in Q2 2022.
  • 175 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.